AASLD Program (pp. 27A-77A)

Jean Millis(Pfizer (United Kingdom)), Laurie Wi(Pfizer (United Kingdom)), B. W. Bacon(Memorial), Adrian M. Di Bisceglie(Saint Louis University), Zachary Goodman(Inova Fairfax Hospital), Estella M. Alonso(Lurie Children's Hospital), John R. Craig(Henry Ford Hospital), Nezam H. Afdhal(Beth Israel Deaconess Medical Center), Kenneth S. Zaret(University of Pennsylvania), Todd H. Baron(University of North Carolina at Chapel Hill), Mohamed Bishr(Purdue Pharma (Canada)), Peter R. Harris(Pfizer (United Kingdom)), William F. Balistreri(Cincinnati Children's Hospital Medical Center), Jay H. Lefkowitch(Columbia College), Thomas Boyer(Centre Hospitalier Universitaire Amiens-Picardie), Keith D. Lindor(Mayo Clinic), Elizabeth M. Brunt(Washington University in St. Louis), Michael Manns(Medizinische Hochschule Hannover), Jenni Sokol(The University of Western Australia), Albert J. Czaja(Mayo Clinic in Arizona), Charles E. Miller(Jet Propulsion Laboratory), J. H. Crawford(Langley Research Center), Omary Ronald(Purdue Pharma (Canada)), Deriiirs msrn(La Roche College), E Heathcute(Purdue Pharma (Canada)), Mitchell Skiffman(Purdue Pharma (Canada)), Sclerosing Cholangitis(Memorial), Cholangiocarcinoma Kirsteiz Boberg(Memorial), Eugene Schifi(Purdue Pharma (Canada)), Lnrcwe Porwll(Bristol-Myers Squibb (Germany)), Anthony Tazdl(Memorial), D Arid, Peter Fererici(Memorial), Michml Czap(Pfizer (United Kingdom)), William Lee(University of British Columbia), Andrew Mason, John M. Belmont(La Roche College), Paul C. Watkins(Harvard University), Bruce R. Bacon(Saint Louis University), James F. Trotter(Baylor Scott & White Health), Kamal G. Ishak(Gilead Sciences (France)), Norali Terrault(La Roche College), Stephanie Wanless(Pfizer (United Kingdom)), Lawrence Friedman(Gilead Sciences (France)), Ronald J. Sokol(Children's Hospital Colorado), Emmet B. Keeffe(Palo Alto University), Saul J. Karpen(Karolinska University Hospital)
Hepatology
October 1, 2003
Cited by 2


Related Papers